Literature DB >> 17101297

Preoperative diagnosis of extrapancreatic neural invasion in pancreatic cancer.

Michael J Levy1, Mark Topazian, Gary Keeney, Jonathan E Clain, Ferga Gleeson, Elizabeth Rajan, Kenneth K Wang, Maurits J Wiersema, Michael Farnell, Suresh Chari.   

Abstract

BACKGROUND & AIMS: Pancreatic cancer recurs in most patients after resection with curative intent. Recurrence is particularly common in patients with extrapancreatic neural invasion (EPNI), the presence of which correlates with poor prognosis. Macroscopic EPNI may be detected with conventional noninvasive imaging and endoscopic ultrasound (EUS) imaging, but microscopic EPNI has required postoperative pathologic examination of surgical specimens. We report the preoperative diagnosis of cancer infiltration into celiac ganglia. We hypothesized that microscopic pancreatic cancer metastasis to neural ganglia can be detected by EUS-guided biopsy examination.
METHODS: We performed a retrospective review of patients with pancreatic cancer undergoing EUS in whom celiac ganglia were sampled to exclude malignant infiltration.
RESULTS: Six patients with pancreatic cancer underwent EUS-guided fine-needle aspiration or trucut biopsy examination of presumed celiac ganglia. Metastatic cancer was found in ganglia of 2 patients. Specimen review identified adenocarcinoma and neural tissue in the absence of lymphocytes. At laparoscopy, 1 of the 2 patients with positive celiac biopsy specimens also had several unexpected peritoneal metastatic deposits. The other patient was considered to have locally advanced unresectable disease. Both patients are receiving supportive care.
CONCLUSIONS: EPNI may be shown preoperatively in patients with pancreatic cancer using EUS-guided sampling of celiac ganglia. A preoperative diagnosis of EPNI has the potential to improve staging accuracy and patient outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 17101297     DOI: 10.1016/j.cgh.2006.08.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  9 in total

1.  Impact of celiac neurolysis on survival in patients with pancreatic cancer.

Authors:  Larissa L Fujii-Lau; William R Bamlet; Jason S Eldrige; Suresh T Chari; Ferga C Gleeson; Barham K Abu Dayyeh; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Elizabeth Rajan; Mark D Topazian; Santhi S Vege; Kenneth K Wang; Maurits J Wiersema; Michael J Levy
Journal:  Gastrointest Endosc       Date:  2015-03-20       Impact factor: 9.427

2.  Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial.

Authors:  Colin S Hill; Lauren Rosati; Hao Wang; Hua-Ling Tsai; Jin He; Amy Hacker-Prietz; Daniel A Laheru; Lei Zheng; Shuchi Sehgal; Vincent Bernard; Dung T Le; Timothy M Pawlik; Matthew J Weiss; Amol K Narang; Joseph M Herman
Journal:  Pract Radiat Oncol       Date:  2022-03-17

3.  Frequency and characterization of celiac ganglia diagnosed on fine-needle aspiration.

Authors:  Ehab A ElGabry; Sara E Monaco; Liron Pantanowitz
Journal:  Cytojournal       Date:  2015-02-18       Impact factor: 2.091

4.  Neural invasion in pancreatic cancer: the past, present and future.

Authors:  Ihsan Ekin Demir; Güralp O Ceyhan; Florian Liebl; Jan G D'Haese; Matthias Maak; Helmut Friess
Journal:  Cancers (Basel)       Date:  2010-07-14       Impact factor: 6.639

5.  How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center.

Authors:  Hao Si-Jie; Xu Wei-Jia; Di Yang; Yao Lie; Yang Feng; Jiang Yong-Jian; Li Ji; Jin Chen; Zhong Liang; Fu De-Liang
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2014-02       Impact factor: 1.719

6.  Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort.

Authors:  Guofeng Zhou; Xiaoyu Liu; Xiaoyi Wang; Dayong Jin; Yi Chen; Guoping Li; Changyu Li; Deliang Fu; Wanghong Xu; Xiaolin Wang
Journal:  Onco Targets Ther       Date:  2017-02-24       Impact factor: 4.147

7.  Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy.

Authors:  Chao-Qun Han; Xue-Lian Tang; Qin Zhang; Chi Nie; Jun Liu; Zhen Ding
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

8.  Factors associated with successful response to neurolytic celiac plexus block in patients with upper abdominal cancer-related pain: a retrospective study.

Authors:  Hyun-Jung Kwon; Kyunghwan Jang; Jeong-Gil Leem; Jin-Woo Shin; Doo-Hwan Kim; Seong-Soo Choi
Journal:  Korean J Pain       Date:  2021-10-01

9.  Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.

Authors:  Colin S Hill; Lauren M Rosati; Chen Hu; Wei Fu; Shuchi Sehgal; Amy Hacker-Prietz; Christopher L Wolfgang; Matthew J Weiss; Richard A Burkhart; Ralph H Hruban; Ana De Jesus-Acosta; Dung T Le; Lei Zheng; Daniel A Laheru; Jin He; Amol K Narang; Joseph M Herman
Journal:  Ann Surg Oncol       Date:  2022-02-07       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.